SUNHO BIOLOGICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.1 HKD | -5.56% |
|
-23.31% | 0.00% |
| May. 24 | Hong Kong Shares End Week in Red; Sunho Biologics Gains in Debut | MT |
| May. 24 | Sunho Biologics Shares Rise 7% in Hong Kong Debut | MT |
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 3.216 | 1.85 | 17.53 |
| EBITDA 1 | -64.21 | -51.54 | -59.88 |
| EBIT 1 | -66.62 | -58.14 | -66.28 |
| Operating Margin | -2,071.39% | -3,142.54% | -378% |
| Earnings before Tax (EBT) 1 | -70.63 | -51.99 | -132.7 |
| Net income 1 | -70.63 | -51.99 | -132.7 |
| Net margin | -2,196.27% | -2,810.16% | -756.82% |
| EPS 2 | -0.7762 | -0.5713 | -1.429 |
| Free Cash Flow | - | -14.87 | 315.7 |
| FCF margin | - | -803.99% | 1,800.63% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 2/9/24 | 2/9/24 | 5/16/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 150 | - | - |
| Net Cash position 1 | - | 2.41 | 201 |
| Leverage (Debt/EBITDA) | -2.339 x | - | - |
| Free Cash Flow | - | -14.9 | 316 |
| ROE (net income / shareholders' equity) | - | 78.1% | 251% |
| ROA (Net income/ Total Assets) | - | -46.6% | -22.9% |
| Assets 1 | - | 111.5 | 578.7 |
| Book Value Per Share 2 | -1.450 | -0.0200 | -1.110 |
| Cash Flow per Share 2 | 0.1200 | 0.0200 | 1.330 |
| Capex 1 | 5.52 | 1.44 | 1.03 |
| Capex / Sales | 171.52% | 77.78% | 5.87% |
| Announcement Date | 2/9/24 | 2/9/24 | 5/16/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 104M | |
| +23.13% | 52.73B | |
| +37.49% | 39B | |
| -8.73% | 38.52B | |
| +28.09% | 30.38B | |
| -12.26% | 26.39B | |
| +10.57% | 26.08B | |
| +45.05% | 14.15B | |
| +32.23% | 12.6B | |
| -6.56% | 11.51B |
- Stock Market
- Equities
- 2898 Stock
- Financials Sunho Biologics, Inc.
